C-646 | m-entrepreneurship.com

Product Name :
C-646

Search keywords :
C646

drugId :
null

Target Vo:
p300-CBP transcription factors

Target Vo Short Name :
p300/CBP

Moa_Name:
p300-CBP transcription factors inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johns Hopkins University

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Neoplasms

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Calbindin Antibody
Phospho-GSK3 beta (Ser9) Antibody
CALCRL Antibody: CALCRL Antibody is an unconjugated, approximately 50 kDa, rabbit-derived, anti-CALCRL polyclonal antibody. CALCRL Antibody can be used for: WB, ELISA expriments in human, mouse, and predicted: rat background without labeling.

Author: Betaine hydrochloride

Related Posts